Subversion of pulmonary dendritic cell function by paramyxovirus infections

Journal of Immunology

Volumn 182, Issue 5, 2009, Pages 3072-3083

  Guerrero Plata, Antonieta ^a   Kolli, Deepthi ^a   Hong, Chao ^a   Casola, Antonella ^a   Garofalo, Roberto P ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; RANTES; TOLL LIKE RECEPTOR 9; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN PRESENTATION; ARTICLE; CD4+ T LYMPHOCYTE; CELL FUNCTION; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENDRITIC CELL; FEMALE; HUMAN METAPNEUMOVIRUS; IN VITRO STUDY; IN VIVO STUDY; LOWER RESPIRATORY TRACT INFECTION; LUNG ALVEOLUS CELL; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; RNA VIRUS INFECTION; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; CELL CULTURE; CELL MOTION; COCULTURE; COMPARATIVE STUDY; DRUG ANTAGONISM; HUMAN; IMMUNOLOGY; LUNG; METABOLISM; METAPNEUMOVIRUS; PATHOLOGY; T LYMPHOCYTE; TRANSGENIC MOUSE; TUMOR CELL LINE; VIRUS INFECTION;

ACUTE DISEASE; ANIMALS; CELL LINE, TUMOR; CELL MOVEMENT; CELLS, CULTURED; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; HUMANS; INTERFERON-ALPHA; LUNG; METAPNEUMOVIRUS; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; PARAMYXOVIRIDAE INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS, HUMAN; T-LYMPHOCYTES;

EID: 64849115293     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0802262     Document Type: Article

References (72)

1. van den Hoogen, B. G., J. C. de Jong, J. Groen, T. Kuiken, R. de Groot, R. A. Fouchier, and A. D. Osterhaus. 2001. A newly discovered human pneumovirus isolated from young children with respiratory tract disease. Nat. Med. 7: 719-724.
2. Hamelin, M. E., and G. Boivin. 2005. Human metapneumovirus: a ubiquitous and long-standing respiratory pathogen. Pediatr. Infect. Dis. J. 24: S203-S207.
3. Esper, F., D. Boucher, C. Weibel, R. A. Martinello, and J. S. Kahn. 2003. Human metapneumovirus infection in the United States: clinical manifestations associated with a newly emerging respiratory infection in children. Pediatrics 111: 1407-1410.
4. Falsey, A. R., D. Erdman, L. J. Anderson, and E. E. Walsh. 2003. Human meta-pneumovirus infections in young and elderly adults. J. Infect. Dis. 187: 785-790.
5. Williams, J. V., P. A. Harris, S. J. Tollefson, L. L. Halburnt-Rush, J. M. Pingsterhaus, K. M. Edwards, P. F. Wright, and J. E. Crowe, Jr. 2004. Human metapneumovirus and lower respiratory tract disease in otherwise healthy infants and children. N. Engl. J. Med. 350: 443-450.
6. Pelletier, G., P. Dery, Y. Abed, and G. Boivin. 2002. Respiratory tract reinfections by the new human Metapneumovirus in an immunocompromised child. Emerg. Infect. Dis. 8: 976-978.
7. Easton, A. J., J. B. Domachowske, and H. F. Rosenberg. 2004. Animal pneumoviruses: molecular genetics and pathogenesis. Clin. Microbiol. Rev. 17: 390-412.
8. van den Hoogen, B. G., G. J. van Doornum, J. C. Fockens, J. J. Cornelissen, W. E. Beyer, R. de Groot, A. D. Osterhaus, and R. A. Fouchier. 2003. Prevalence and clinical symptoms of human metapneumovirus infection in hospitalized patients. J. Infect. Dis. 188: 1571-1577.
9. Kahn, J. S. 2003. Human metapneumovirus: a newly emerging respiratory pathogen. Curr. Opin. Infect. Dis. 16: 255-258.
10. von Linstow, M. L., L. H. Henrik, J. Eugen-Olsen, A. Koch, W. T. Nordmann, A. M. Meyer, H. Westh, B. Lundgren, M. Melbye, and B. Hogh. 2004. Human metapneumovirus and respiratory syncytial virus in hospitalized Danish children with acute respiratory tract infection. Scand. J. Infect. Dis. 36: 578-584.
11. Hall, C. B., E. E. Walsh, C. E. Long, and K. C. Schnabel. 1991. Immunity to and frequency of reinfection with respiratory syncytial virus. J. Infect. Dis. 163: 693-698.
12. Garcia-Garcia, M. L., C. Calvo, I. Casas, T. Bracamonte, A. Rellan, F. Gozalo, T. Tenorio, and P. Perez-Brena. 2007. Human metapneumovirus bronchiolitis in infancy is an important risk factor for asthma at age 5. Pediatr. Pulm. 42: 458-464.
13. Webb, M. S. C., R. L. Henry, and A. D. Milner. 1985. Continuing respiratory problems three and a half years after acute viral bronchiolitis. Arch. Dis. Child. 60: 1064-1067.
14. Banchereau, J., F. Briere, C. Caux, J. Davoust, S. Lebecque, Y. J. Liu, B. Pulendran, and K. Palucka. 2000. Immunobiology of dendritic cells. Annu. Rev. Immunol. 18: 767-811.
15. Pulendran, B., K. Palucka, and J. Banchereau. 2001. Sensing pathogens and tuning immune responses. Science 293: 253-256.
16. Mellman, I., and R. M. Steinman. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106: 255-258.
17. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311: 17-58.
18. Stumbles, P. A., J. W. Upham, and P. G. Holt. 2003. Airway dendritic cells: co-ordinators of immunological homeostasis and immunity in the respiratory tract. APMIS 111: 741-755.
19. Barchet, W., M. Cella, and M. Colonna. 2005. Plasmacytoid dendritic cells: virus experts of innate immunity. Semin. Immunol. 17: 253-261.
20. Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor α. J. Exp. Med. 179: 1109-1118.
21. Chan, C. W., E. Crafton, H. N. Fan, J. Flook, K. Yoshimura, M. Skarica, D. Brockstedt, T. W. Dubensky, M. F. Stins, L. L. Lanier, et al. 2006. Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity. Nat. Med. 12: 207-213.
22. Taieb, J., N. Chaput, C. Menard, L. Apetoh, E. Ullrich, M. Bonmort, M. Pequignot, N. Casares, M. Terme, C. Flament, et al. 2006. A novel dendritic cell subset involved in tumor immunosurveillance. Nat. Med. 12: 214-219.
23. Bonmort, M., M. Dalod, G. Mignot, E. Ullrich, N. Chaput, and L. Zitvogel. 2008. Killer dendritic cells: IKDC and the others. Curr. Opin. Immunol. 20: 558-565.
24. Chauvin, C., and R. Josien. 2008. Dendritic cells as killers: mechanistic aspects and potential roles. J. Immunol. 181: 11-16.
25. Ueba, O. 1978. Respiratory syncytial virus: I. concentration and purification of the infectious virus. Acta Med. 32: 265-272.
26. Guerrero-Plata, A., A. Casola, and R. P. Garofalo. 2005. Human metapneumovirus induces a profile of lung cytokines distinct from that of respiratory syncytial virus. J. Virol. 79: 14992-14997.
27. Haeberle, H. A., W. A. Kuziel, H.-J. Dieterich, A. Casola, Z. Gatalica, and R. P. Garofalo. 2000. Inducible expression of inflammatory chemokines in respiratory syncytial virus-infected mice: role of MIP-1a in lung pathology. J. Virol. 75: 878-890.
28. von Andrian, U. H., and T. R. Mempel. 2003. Homing and cellular traffic in lymph nodes. Nat. Rev. Immunol. 3: 867-878.
29. Guerrero-Plata, A., A. Casola, G. Suarez, X. Yu, L. Spetch, M. E. Peeples, and R. P. Garofalo. 2006. Differential response of dendritic cells to human metapneumovirus and respiratory syncytial virus. Am. J. Respir. Cell Mol. Biol. 34: 320-329.
30. Pohl, C., J. Shishkova, and S. Schneider-Schaulies. 2007. Viruses and dendritic cells: enemy mine. Cell. Microbiol. 9: 279-289.
31. Schlender, J., V. Hornung, S. Finke, M. Gunthner-Biller, S. Marozin, K. Brzozka, S. Moghim, S. Endres, G. Hartmann, and K. K. Conzelmann. 2005. Inhibition of toll-like receptor 7- and 9-mediated α/β interferon production in human plasmacytoid dendritic cells by respiratory syncytial virus and measles virus. J. Virol. 79: 5507-5515.
32. 7 integrin-positive epithelial dendritic cell population expressing Langerin and tight junction proteins. J. Immunol. 176: 2161-2172.
33. + T cells. J. Immunol. 178: 6861-6866.
34. + regulatory T cells via a TGF-β and retinoic acid-dependent mechanism. J. Exp. Med. 204: 1757-1764.
35. 7 integrin. Nature 372: 190-193.
36. Palucka, K., and J. Banchereau. 2002. How dendritic cells and microbes interact to elicit or subvert protective immune responses. Curr. Opin. Immunol. 14: 420-431.
37. de Graaff, P. M., E. C. de Jong, T. M. van Capel, M. E. van Dijk, P. J. Roholl, J. Boes, W. Luytjes, J. L. Kimpen, and G. M. van Bleek. 2005. Respiratory syncytial virus infection of monocyte-derived dendritic cells decreases their capacity to activate CD4 T cells. J. Immunol. 175: 5904-5911.
38. Grayson, M. H., and M. J. Holtzman. 2007. Emerging role of dendritic cells in respiratory viral infection. J. Mol. Med. 85: 1057-1068.
39. Gill, M. A., A. K. Palucka, T. Barton, F. Ghaffar, H. Jafri, J. Banchereau, and O. Ramilo. 2005. Mobilization of plasmacytoid and myeloid dendritic cells to mucosal sites in children with respiratory syncytial virus and other viral respiratory infections. J. Infect. Dis. 191: 1105-1115.
40. Smit, J. J., B. D. Rudd, and N. W. Lukacs. 2006. Plasmacytoid dendritic cells inhibit pulmonary immunopathology and promote clearance of respiratory syncytial virus. J. Exp. Med. 203: 1153-1159.
41. Vremec, D., M. O'Keeffe, H. Hochrein, M. Fuchsberger, I. Caminschi, M. Lahoud, and K. Shortman. 2007. Production of interferons by dendritic cells, plasmacytoid cells, natural killer cells, and interferon-producing killer dendritic cells. Blood 109: 1165-1173.
42. Krug, A., A. R. French, W. Barchet, J. A. Fischer, A. Dzionek, J. T. Pingel, M. M. Orihuela, S. Akira, W. M. Yokoyama, and M. Colonna. 2004. TLR9-dependent recognition of MCMV by IPC and DC generates coordinated cytokine responses that activate antiviral NK cell function. Immunity 21: 107-119.
43. Colonna, M., G. Trinchieri, and Y. J. Liu. 2004. Plasmacytoid dendritic cells in immunity. Nat. Immunol. 5: 1219-1226.
44. + cells identify them as a subset of NK cells. J. Exp. Med. 204: 2561-2568.
45. Beyer, M., H. Bartz, K. Horner, S. Doths, C. Koerner-Rettberg, and J. Schwarze. 2004. Sustained increases in numbers of pulmonary dendritic cells after respiratory syncytial virus infection. J. Allergy Clin. Immunol. 113: 127-133.
46. + interferon-producing killer dendritic cells are activated natural killer cells. J. Exp. Med. 204: 2569-2578.
47. + lymphoid progenitors. Blood 109: 4825-4931.
48. Caminschi, I., F. Ahmet, K. Heger, J. Brady, S. L. Nutt, D. Vremec, S. Pietersz, M. H. Lahoud, L. Schofield, D. S. Hansen, et al. 2007. Putative IKDCs are functionally and developmentally similar to natural killer cells, but not to dendritic cells. J. Exp. Med. 204: 2579-2590.
49. Spits, H., and L. L. Lanier. 2007. Natural killer or dendritic: what's in a name? Immunity 26: 11-16.
50. Kolli, D., E. L. Bataki, L. Spetch, A. Guerrero-Plata, A. M. Jewell, P. A. Piedra, G. N. Milligan, R. P. Garofalo, and A. Casola. 2008. T lymphocytes contribute to antiviral immunity and pathogenesis in experimental human metapneumovirus infection. J. Virol. 82: 8560-8569.
51. Hornung, V., J. Schlender, M. Guenthner-Biller, S. Rothenfusser, S. Endres, K. K. Conzelmann, and G. Hartmann. 2004. Replication-dependent potent IFN-α induction in human plasmacytoid dendritic cells by a single-stranded RNA virus. J. Immunol. 173: 5935-5943.
52. Jewell, N. A., N. Vaghefi, S. E. Mertz, P. Akter, R. S. Peebles, Jr., L. O. Bakaletz, R. K. Durbin, E. Flano, and J. E. Durbin. 2007. Differential type I interferon induction by respiratory syncytial virus and influenza a virus in vivo. J. Virol. 81: 9790-9800.
53. Pribul, P. K., J. Harker, B. Wang, H. Wang, J. S. Tregoning, J. Schwarze, and P. J. Openshaw. 2008. Alveolar macrophages are a major determinant of early responses to viral lung infection but do not influence subsequent disease development. J. Virol. 89: 4441-4448.
54. Guerrero-Plata, A., S. Baron, J. S. Poast, P. A. Adegboyega, A. Casola, and R. P. Garofalo. 2005. Activity and regulation of α interferon in respiratory syncytial virus and human metapneumovirus experimental infections. J. Virol. 79: 10190-10199.
55. Didierlaurent, A., J. Goulding, S. Patel, R. Snelgrove, L. Low, M. Bebien, T. Lawrence, L. S. van Rijt, B. N. Lambrecht, J. C. Sirard, and T. Hussell. 2008. Sustained desensitization to bacterial Toll-like receptor ligands after resolution of respiratory influenza infection. J. Exp. Med. 205: 323-329.
56. Boivin, G., Y. Abed, G. Pelletier, L. Ruel, D. Moisan, S. Cote, T. C. Peret, D. D. Erdman, and L. J. Anderson. 2002. Virological features and clinical manifestations associated with human metapneumovirus: a new paramyxovirus responsible for acute respiratory-tract infections in all age groups. J. Infect. Dis. 186: 1330-1334.
57. Hall, C. B., K. R. Powell, N. E. MacDonald, C. L. Gala, M. E. Menegus, S. C. Suffin, and H. J. Cohen. 1986. Respiratory syncytial viral infection in children with compromised immune function. N. Engl. J. Med. 315: 77-81.
58. Welliver, T. P., R. P. Garofalo, Y. Hosakote, K. H. Hintz, L. Avendano, K. Sanchez, L. Velozo, H. Jafri, S. Chavez-Bueno, P. L. Ogra, et al. 2007. Severe human lower respiratory tract illness caused by respiratory syncytial virus and influenza virus is characterized by the absence of pulmonary cytotoxic lymphocyte responses. J. Infect. Dis. 195: 1126-1136.
59. Schlender, J., G. Walliser, J. Fricke, and K. K. Conzelmann. 2002. Respiratory syncytial virus fusion protein mediates inhibition of mitogen-induced T-cell proliferation by contact. J. Virol. 76: 1163-1170.
60. Preston, F. M., P. L. Beier, and J. H. Pope. 1995. Identification of the respiratory syncytial virus-induced immunosuppressive factor produced by human peripheral blood mononuclear cells in vitro as interferon-α. J. Infect. Dis. 172: 919-926.
61. Salkind, A. R., D. O. McCarthy, J. E. Nichols, F. M. Domurat, E. E. Walsh, and N. J. Roberts, Jr. 1991. Interleukin-1-inhibitor activity induced by respiratory syncytial virus: abrogation of virus-specific and alternate human lymphocyte proliferative responses. J. Infect. Dis. 163: 71-77.
62. Preston, F. M., P. L. Beier, and J. H. Pope. 1992. Infectious respiratory syncytial virus (RSV) effectively inhibits the proliferative T cell response to inactivated RSV in vitro. J. Infect. Dis. 165: 819-825.
63. Chi, B., H. L. Dickensheets, K. M. Spann, M. A. Alston, C. Luongo, L. Dumoutier, J. Huang, J. C. Renauld, S. V. Kotenko, M. Roederer, et al. 2006. α and λ interferon together mediate suppression of CD4 T cells induced by respiratory syncytial virus. J. Virol. 80: 5032-5040.
64. Greenwald, R. J., G. J. Freeman, and A. H. Sharpe. 2005. The B7 family revisited. Annu. Rev. Immunol. 23: 515-548.
65. Latchman, Y., C. R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A. J. Long, J. A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2: 261-268.
66. Tseng, S. Y., M. Otsuji, K. Gorski, X. Huang, J. E. Slansky, S. I. Pai, A. Shalabi, T. Shin, D. M. Pardoll, and H. Tsuchiya. 2001. B7-DC, a new dendritic cell molecule with potent costimulatory properties for T cells. J. Exp. Med. 193: 839-846.
67. + T cell activation and cytolysis. Eur. J. Immunol. 33: 3117-3126.
68. Freeman, G. J., V. A. Boussiotis, A. Anumanthan, G. M. Bernstein, X.-Y. Ke, P. D. Rennert, G. S. Gray, J. G. Gribben, and L. M. Nadler. 1995. B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially costimulates the initial production of IL-4. Immunity 2: 523-532.
69. Stanciu, L. A., C. M. Bellettato, V. Laza-Stanca, A. J. Coyle, A. Papi, and S. L. Johnston. 2006. Expression of programmed death-1 ligand (PD-L) 1, PDL2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J. Infect. Dis. 193: 404-412.
70. + suppressor T cells in vivo. Nat. Immunol. 3: 33-41.
71. Annacker, O., J. L. Coombes, V. Malmstrom, H. H. Uhlig, T. Bourne, B. Johansson-Lindbom, W. W. Agace, C. M. Parker, and F. Powrie. 2005. Essential role for CD103 in the T cell-mediated regulation of experimental colitis. J. Exp. Med. 202: 1051-1061.
72. + dendritic cells in the regulation of tissue-selective T cell homing. J. Exp. Med. 202: 1063-1073.